Status: current, Defined. Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089077019 | Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 5089078012 | Azacitidine 100 mg powder for suspension for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Azacitidine 100 mg powder for suspension for injection vial | Is a | Azacitidine only product in parenteral dose form | true | Inferred relationship | Some | ||
| Azacitidine 100 mg powder for suspension for injection vial | Has manufactured dose form | Powder for suspension for injection | true | Inferred relationship | Some | ||
| Azacitidine 100 mg powder for suspension for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Azacitidine 100 mg powder for suspension for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Azacitidine 100 mg powder for suspension for injection vial | Has precise active ingredient | Azacitidine | true | Inferred relationship | Some | 1 | |
| Azacitidine 100 mg powder for suspension for injection vial | Has BoSS | Azacitidine | true | Inferred relationship | Some | 1 | |
| Azacitidine 100 mg powder for suspension for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Azacitidine 100 mg powder for suspension for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR